For years PBMs have been assailed by pharma companies and Congress, and the new Trump administration looks likely to keep up the barrage.

The parents of Cole Schmidtknecht, 22, are suing Walgreens and OptumRx, a subsidiary of UnitedHealth Group, over the Wisconsin man's death in 2024.

CVS CEO David Joyner’s comments come as lawmakers on both sides of the aisle and President Donald Trump have signaled ...

We spoke recently with Craig Burton, MBA, executive director of the Biosimilars Council, a trade and lobbying group for the ...

Diagnosed with asthma as a baby, Cole Schmidtknecht took the inhaler daily as a preventive medication since he was about 13, ...

United Health Group’s pharmacy benefit manager, Optum Rx, stopped covering Cole Schmidtknecht’s ‘life-changing’ inhaler, suit ...

Healthcare startup Capital Rx seeing revenue surge as Congress seeks to regulate the PBM giants that profit from high drug ...

The bill would allow pharmacies to decline dispensing prescriptions to people if that pharmacy would be reimbursed less than ...

The two have mended fences after a nasty contract dispute in 2022 caused Kroger pharmacies to go out of network with Express ...

The FTC called out the nation’s leading pharmacy benefit managers for inflating pharmacy costs, affecting both employers and ...

Pharmacists in the Four-States say their livelihoods are at risk as major companies gain more control of the drug market. They're warning that Pharmacy Benefit Mangers, better known as PBMs, have an ...

Pharmacies are closing at an alarming rate — most of them, including Walgreens, independent from PBMs — due to unfair reimbursement practices by a few large, vertically integrated conglomerates.